Business Wire

REPLY

24.1.2024 09:31:30 CET | Business Wire | Press release

Share
Reply Presents "AI Live Posting", a Solution That Revolutionises the Creation of Content for Social Media Teams through Generative Artificial Intelligence

Developed by TamTamy Reply, the Reply group company specialising in the design and development of digital communities, AI Live Posting utilises generative artificial intelligence and automation to support the creative and editorial activities of Social Media Teams, giving them a new approach to content creation and empowering them to promote events in real-time with increased user engagement on social media platforms.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240124991622/en/

To view this piece of content from mms.businesswire.com, please give your consent at the top of this page.

AI Live Posting transforms real-time spoken content into captivating posts. This solution leverages AI technology to transcribe and analyze spoken content in real-time, converting it into engaging written posts. In addition, the AI algorithms automatically create visually appealing images that complement the posts and generates open questions related to the spoken content itself. (Photo: Business Wire)

AI Live Posting shines in live event scenarios, where it captures real-time speeches and instantly transforms them into engaging posts. Leveraging artificial intelligence, speeches are transcribed, analysed, and converted into captivating posts, akin to tweets, enriched with creative visuals ready to be shared across various social or mobile platforms. The solution offers flexibility in customising the tone of the text and the style of the generated images, making it suitable for various types of events such as conferences, product launches, and sports events.

With AI Live Posting, Social Media teams can benefit from a solution that enhances their creativity, generating unique and engaging content tailored to their target audience, while also improving productivity. Thanks to the integrated artificial intelligence engine, utilising OpenAI and Stable Diffusion technologies, it is possible to automatically create and publish new textual and visual content in real-time, reducing the need for manual extraction and reworking of information. Manual intervention, required for content review through a dedicated dashboard and post-moderation on channels, ensures consistency with the brand identity, preserving greater speed in content creation and publication.

AI Live Posting can be used as a standalone solution or in combination with TamTamy, Reply's proprietary Digital Workplace and Enterprise Social Network platform.

For more information on AI Live Posting and Reply's generative AI-based solutions, visit www.ai.reply.com.

Reply
Reply [EXM, STAR: REY] specialises in the design and implementation of solutions based on new communication channels and digital media. Reply is a network of highly specialised companies supporting key European industrial groups operating in the telecom and media, industry and services, banking, insurance and public administration sectors in the definition and development of business models enabled for the new paradigms of big data, cloud computing, digital media and the Internet of Things. Reply services include: Consulting, System Integration and Digital Services. www.reply.com

TamTamy Reply
TamTamy Reply is the Reply group company specialized in the design and development of digital communities, social learning platforms, social intranets, and digital workplaces. Through its proprietary enterprise social networking platform, TamTamy Reply supports its clients in various contexts and sectors. This includes the design of digital communication initiatives, community systems, and content management, as well as the definition of internal communication strategies and the implementation of launch campaigns and employee engagement. Visit www.tamtamyreply.com for more information.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240124991622/en/

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com
DK

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Okomera Strengthens Its Leadership Team With the Appointment of Marion Ghibaudo as Chief Technology Officer16.9.2026 08:00:00 CEST | Press release

An expert in scaling medical innovations, Marion Ghibaudo joins Okomera as the company advances toward industrial deployment. Okomera, a TechBio company pioneering next-generation cancer care through the development of a proprietary technology platform combining tumor mini-avatars, microfluidics, and AI-powered imaging, today announced the appointment of Marion Ghibaudo as Chief Technology Officer. She will spearhead the company’s technology and innovation strategy and lead the industrial deployment of its integrated hardware, software, and biological platform. Marion Ghibaudo will join Okomera’s Executive Committee and report to CEO Silvère Lucquin. In parallel, Raphaël Tomasi, Okomera’s co-founder and former CTO, transitions to the role of VP Platform, ensuring continuity in the development of the company’s technology platform. Marion’s appointment comes at a key stage in Okomera’s growth as the company advances toward pilot studies, industrial scale-up, and commercialization. Okomer

Galderma’s Restylane® Volyme™ Demonstrates High Effectiveness, Satisfaction and a Robust Safety Profile in Chinese Patients With Temple Hollowing16.9.2026 07:00:00 CEST | Press release

Positive topline results showed that Restylane Volyme (known as Restylane Contour in the U.S.) was highly effective in the correction of moderate-to-severe temple hollowing, with high responder rates maintained through Month 121 Restylane Volyme was well tolerated, with no incidences of granulomas. Patient and investigator satisfaction were also high1 These data support Galderma’s aim to expand the availability of the Restylane portfolio in China – a market undergoing significant expansion, and further strengthen Restylane’s vast clinical evidence base2,3 Galderma (SIX: GALD) today announced positive topline results from a study of Restylane Volyme for the correction of moderate-to-severe temple hollowing in 162 patients in China.1 The study met its primary endpoint, demonstrating the effectiveness and safety of Restylane Volyme versus a no-treatment control, while also achieving high patient and investigator satisfaction.1 These data further reinforce Galderma's ambition to expand its

Nippon Electric Glass’s IR Transmitting Glass “FI-02” Adopted for Heimann Sensor Lens Unit, Enabling a 120° × 68° Field of View16.9.2026 03:00:00 CEST | Press release

Nippon Electric Glass Co., Ltd. (NEG) (TOKYO: 5214), a global leader in specialty glass headquartered in Otsu, Japan, announced that its IR Transmitting Glass (chalcogenide glass) “FI-02” has been adopted for Heimann Sensor GmbH’s wide-angle lens unit for thermal cameras. The lens unit achieves a 120° × 68° field of view, surpassing the previous product’s maximum of 92° × 59°. The adoption marks a significant milestone for FI-02 and showcases how advanced specialty glass can meet the demanding optical and manufacturing requirements of the expanding infrared sensing market. Thermal cameras detect infrared radiation emitted by people or objects and convert it into thermal images. Infrared sensors can detect the locations of people and temperature distributions. They are expected to be used for people detection and monitoring, where privacy considerations are important, and for air-conditioning control, while their use is expanding in healthcare, equipment monitoring, and security. Advanc

Workiva Advances Regulatory Work with AI Innovation15.9.2026 17:00:00 CEST | Press release

Agent Studio anchors AI capabilities unveiled at Amplify 2026 Workiva Inc. (NYSE: WK), a leading, audit-ready platform for trust, transparency, and accountability, unveiled dozens of new product and platform innovations at Amplify 2026, the company’s annual conference attended by thousands of finance, accounting, sustainability, risk, and compliance leaders. Workiva Debuts Agent Studio Workiva introduced Agent Studio, a landmark platform capability that empowers users to quickly build, customize, and deploy AI agents in Workiva's trusted platform. By combining AI reasoning with Workiva's native platform capabilities, enterprise knowledge, and governed workflows, Agent Studio enables users to automate sophisticated manual business processes without writing any code. Organizations can enrich agents with company-specific knowledge and context, tailor them to their own processes, and schedule automations to execute recurring work. “With Agent Studio, we're putting the power to build in the

Study: Heatwaves Increase Cough Urge, Which Salt Aerosols Reduce15.9.2026 15:15:00 CEST | Press release

New Study Indicates Non-Pharmacological Aerosol May Provide Therapeutic Relief for Respiratory Conditions Provoked by the Atmospheric Aridity Inherent to Heatwaves SC Therapeutics, with University North Carolina, Imperial College London, and Boston University, announced publication on Tuesday in Nature Scientific Reports of results from a multi-institutional study indicating that the aridity inherent in heatwaves increases cough hypersensitivity in human airways by collapsing mucus onto cilia in a manner common to chronic respiratory diseases, such as cystic fibrosis, and asthma. The researchers find that alkaline aerosols of magnesium salts reverse mucosal collapse for several hours, and reduce cough hypersensitivity as reflected in placebo-adjusted suppression of daily cough bout rate (59%, p=0.03) and persistence of suppression post treatment for 1 to 3 weeks in a randomized, double-blind, placebo-controlled study of 10 refractory chronic cough patients. “Paris recorded 5,764 excess

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye